Bob Hombach

(Mr. Robert Hombach CPA)

Currently holds positions in Baxalta Inc, Biomarin Pharmaceutical Inc, Carmax Inc and Aptinyx Inc

Positions

Position Company Period
Chief Financial Officer, Chief Operating Officer, Executive Vice President Baxalta Inc None -
Independent Director Biomarin Pharmaceutical Inc Sept. 28, 2017 -
Independent Director Carmax Inc April 1, 2018 -
Independent Director Aptinyx Inc May 1, 2018 -
Chief Financial Officer, Corporate Vice President Baxter International Inc March 23, 2011 - Jan. 1, 2015
Bob Hombach's trades of Aptinyx Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2021-11-15 2021-11-12 B Purchase
74,600 +51.6%
2.40
USD 179,040
74,600 +51.6% 2.40 USD 179,040
2021-11-15 2021-11-11 B Purchase
5,400 +3.9%
2.40
USD 12,960
5,400 +3.9% 2.40 USD 12,960
2020-01-14 2020-01-10 B Purchase
50,000 +56.1%
3.00
USD 150,000
50,000 +56.1% 3.00 USD 150,000
2019-01-28 2019-01-25 B Purchase
11,655 +31.1%
5.54
USD 64,569
11,655 +31.1% 5.54 USD 64,569
2019-01-28 2019-01-24 B Purchase
13,345 +55.4%
5.52
USD 73,664
13,345 +55.4% 5.52 USD 73,664
// ... existing code ... // ... rest of the file ...